Abstract
The secondary oxalosis of renal failure has been recognised for more than 20 years (Bennett and Rosenblum, 1961), but details of its prevalence and clinical features have been addressed only recently(Salyer and Keren, 1973; Boer et al., 1984; Pru et al., 1985). Oxalate is a non-metabolisable end product of glycine and ascorbic acid metabolism(Elder and Wyngaarden, 1960) and virtually all of it is excreted by the kidneys. Renal insufficiency can produce oxalate loads that exceed renal excretory capacity. Protein binding of oxalate is minimal and most of it should be removed by hemodialysis. However, hemodialysis does not remove oxalate as fast as it is formed, leaving patients at risk from the complications which result from systemic oxalosis (Landwehr et al., 1987).KeywordsOxalic AcidUrinary OxalateCalcium Oxalate CrystalRemnant KidneyPlasma OxalateThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.